94 related articles for article (PubMed ID: 21892705)
21. The role of TP53 PRO47SER and ARG72PRO single nucleotide polymorphisms in the susceptibility to bladder cancer.
Santos LE; Guilhen AC; de Andrade RA; Sumi LG; Ward LS
Urol Oncol; 2011; 29(3):291-4. PubMed ID: 19523860
[TBL] [Abstract][Full Text] [Related]
22. Polymorphic deletions of the GSTT1 and GSTM1 genes and susceptibility to bladder cancer.
Salinas-Sánchez AS; Sánchez-Sánchez F; Donate-Moreno MJ; Rubio-del-Campo A; Gimenez-Bachs JM; Lorenzo-Romero JG; Serrano-Oviedo L; Escribano J
BJU Int; 2011 Jun; 107(11):1825-32. PubMed ID: 20942828
[TBL] [Abstract][Full Text] [Related]
23. A new single nucleotide polymorphism in the insulin-like growth factor I regulatory region associates with colorectal cancer risk in singapore chinese.
Wong HL; Delellis K; Probst-Hensch N; Koh WP; Van Den Berg D; Lee HP; Yu MC; Ingles SA
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):144-51. PubMed ID: 15668488
[TBL] [Abstract][Full Text] [Related]
24. The role of IGFBP3 functional polymorphisms in the risk of gastric cancer in a high-risk Chinese population.
Chen W; Wang L; Ke Q; Jin G; Tan Y; Zhou Y; Hu Z; Ma H; Wang J; Hua Z; Ding W; Shen J; Xu Y; Shen H
Eur J Cancer Prev; 2008 Apr; 17(2):82-7. PubMed ID: 18287864
[TBL] [Abstract][Full Text] [Related]
25. Genetic variation in the growth hormone synthesis pathway in relation to circulating insulin-like growth factor-I, insulin-like growth factor binding protein-3, and breast cancer risk: results from the European prospective investigation into cancer and nutrition study.
Canzian F; McKay JD; Cleveland RJ; Dossus L; Biessy C; Boillot C; Rinaldi S; Llewellyn M; Chajès V; Clavel-Chapelon F; Téhard B; Chang-Claude J; Linseisen J; Lahmann PH; Pischon T; Trichopoulos D; Trichopoulou A; Zilis D; Palli D; Tumino R; Vineis P; Berrino F; Bueno-de-Mesquita HB; van Gils CH; Peeters PH; Pera G; Barricarte A; Chirlaque MD; Quirós JR; Larrañaga N; Martínez-García C; Allen NE; Key TJ; Bingham SA; Khaw KT; Slimani N; Norat T; Riboli E; Kaaks R
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2316-25. PubMed ID: 16214911
[TBL] [Abstract][Full Text] [Related]
26. Role of polymorphisms of the IGF2 and IGFBP3 genes and risk of gastric carcinoma in China.
Gu J; Li M; Dong P; Lu J; Tan Z; Wu X; Mu J; Zhang L; Wu W; Ding Q; Yang J; Cao Y; Ding Q; Weng H; Liu Y
Chin Med J (Engl); 2014; 127(3):412-6. PubMed ID: 24451943
[TBL] [Abstract][Full Text] [Related]
27. Association of an exon 1 polymorphism in the IGFBP3 gene with circulating IGFBP-3 levels and colorectal cancer risk: the multiethnic cohort study.
Le Marchand L; Kolonel LN; Henderson BE; Wilkens LR
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1319-21. PubMed ID: 15894694
[TBL] [Abstract][Full Text] [Related]
28. XPD codon 751 polymorphism, metabolism genes, smoking, and bladder cancer risk.
Stern MC; Johnson LR; Bell DA; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2002 Oct; 11(10 Pt 1):1004-11. PubMed ID: 12376500
[TBL] [Abstract][Full Text] [Related]
29. Profiling of genetic variations in inflammation pathway genes in relation to bladder cancer predisposition.
Yang H; Gu J; Lin X; Grossman HB; Ye Y; Dinney CP; Wu X
Clin Cancer Res; 2008 Apr; 14(7):2236-44. PubMed ID: 18381966
[TBL] [Abstract][Full Text] [Related]
30. Genetic polymorphisms involved in insulin-like growth factor (IGF) pathway in relation to mammographic breast density and IGF levels.
Diorio C; Brisson J; Bérubé S; Pollak M
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):880-8. PubMed ID: 18398029
[TBL] [Abstract][Full Text] [Related]
31. Genetic variants in cell cycle control pathway confer susceptibility to bladder cancer.
Ye Y; Yang H; Grossman HB; Dinney C; Wu X; Gu J
Cancer; 2008 Jun; 112(11):2467-74. PubMed ID: 18361427
[TBL] [Abstract][Full Text] [Related]
32. Identification of novel potential genetic predictors of urothelial bladder carcinoma susceptibility in Pakistani population.
Ali SHB; Bangash KS; Rauf A; Younis M; Anwar K; Khurram R; Khawaja MA; Azam M; Qureshi AA; Akhter S; Kiemeney LA; Qamar R
Fam Cancer; 2017 Oct; 16(4):577-594. PubMed ID: 28386678
[TBL] [Abstract][Full Text] [Related]
33. Common genetic variation in the IGF1 associates with maximal force output.
Huuskonen A; Lappalainen J; Oksala N; Santtila M; Häkkinen K; Kyröläinen H; Atalay M
Med Sci Sports Exerc; 2011 Dec; 43(12):2368-74. PubMed ID: 21552154
[TBL] [Abstract][Full Text] [Related]
34. Arylamine N-acetyltransferase 1 (NAT1) and 2 (NAT2) polymorphisms in susceptibility to bladder cancer: the influence of smoking.
Okkels H; Sigsgaard T; Wolf H; Autrup H
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):225-31. PubMed ID: 9107426
[TBL] [Abstract][Full Text] [Related]
35. Polymorphisms in the IGF-1 and IGFBP 3 promoter and the risk of breast cancer.
Wagner K; Hemminki K; Israelsson E; Grzybowska E; Söderberg M; Pamula J; Pekala W; Zientek H; Mielzynska D; Siwinska E; Försti A
Breast Cancer Res Treat; 2005 Jul; 92(2):133-40. PubMed ID: 15986122
[TBL] [Abstract][Full Text] [Related]
36. DNA repair gene XRCC1 polymorphisms, smoking, and bladder cancer risk.
Stern MC; Umbach DM; van Gils CH; Lunn RM; Taylor JA
Cancer Epidemiol Biomarkers Prev; 2001 Feb; 10(2):125-31. PubMed ID: 11219769
[TBL] [Abstract][Full Text] [Related]
37. Association between acromegaly and a single nucleotide polymorphism (rs2854744) in the IGFBP3 gene.
Gao M; Zhu B; Xu Z; Liu S; Liu J; Zhang G; Gao Y; Fan Y; Kang X
BMC Med Genet; 2018 Oct; 19(1):182. PubMed ID: 30290787
[TBL] [Abstract][Full Text] [Related]
38. [Association between genetic polymorphism of UGT1A7 and susceptibility of bladder cancer].
Liu J; Yang XM; Liu G; Chang LS; Zhang LR; Song DK
Zhonghua Yi Xue Za Zhi; 2009 Dec; 89(44):3122-5. PubMed ID: 20193274
[TBL] [Abstract][Full Text] [Related]
39. Cancer risk factors associated with insulin-like growth factor (IGF)-I and IGF-binding protein-3 levels in healthy women: effect modification by menopausal status.
Barnes BB; Chang-Claude J; Flesch-Janys D; Kinscherf R; Schmidt M; Slanger T; Bonaterra G; Steindorf K
Cancer Causes Control; 2009 Dec; 20(10):1985-96. PubMed ID: 19597750
[TBL] [Abstract][Full Text] [Related]
40. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder.
Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
Br J Cancer; 2005 Jun; 92(12):2262-5. PubMed ID: 15886698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]